Vancomycin-resistant enterococcal bacteremia:: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis

被引:0
|
作者
Chou, Yen-Yi [1 ]
Lin, Te-Yu [1 ]
Lin, Jung-Chung [1 ]
Wang, Ning-Chi [1 ]
Peng, Ming-Yieh [1 ]
Chang, Feng-Yee [1 ]
机构
[1] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Med, Div Infect Dis & Trop Med, Taipei 114, Taiwan
关键词
bacteremia; Enterococcus faecalis; Enterococcus faecium; vancomycin resistance;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background and Purpose: Vancomycin-resistant enterococci (VRE) have emerged as important nosocomial pathogens. This study was conducted to clarify the clinical features and outcome of patients with vancomycin-resistant enterococcal bacteremia. Methods: Patients with vancomycin-resistant enterococcal bacteremia treated at a medical center in northern Taiwan between November 1998 and July 2006 were reviewed. Clinical and bacteriological characteristics of Enterococcus faecium and Enterococcus faecalis were compared. Results: Twelve patients (6 males and 6 females) were included for analyses. The mean age was 69.3 years (range, 40 to 86 years), and 8 cases (66.7%) were older than 65 years. All patients had underlying disease. Two patients received total hip replacement before development of VRE bacteremia. Twelve patients had prior exposure to broad-spectrum antimicrobial therapy. Ten patients had prior intensive care unit stay and prior mechanical ventilation before VRE bacteremia. All of the patients (n = 12) had an intravascular catheter in place. Bacteremia was caused by E faecalis in 4 patients and by E faecium in eight. The portals of entry included urinary tract (8.3%), skin, soft tissue and bone (41.7%) and unknown sources (50.0%). E faecium showed a higher rate of resistance to ampicillin and teicoplanin than E faecalis (87.5% vs 0.0%, p=0.01). The 60-day mortality rate was higher in patients with E. faecium bacteremia than E faecalis bacteremia (62.5% vs 0.0%), although statistical significance was not obtained (p=0.08). Conclusions: VRE bacteremia may have an impact on the mortality and morbidity of hospitalized patients. Patients with bacteremia caused by vancomycin-resistant E faecium had a grave prognosis, especially immuno-suppressed patients. The prudent use of antibiotics and strict enforcement of infection control may prevent further emergence and spread of VRE.
引用
下载
收藏
页码:124 / 129
页数:6
相关论文
共 50 条
  • [1] Comparison of the Clinical Characteristics and Outcomes Associated with Vancomycin-Resistant Enterococcus faecalis and Vancomycin-Resistant E. faecium Bacteremia
    Hayakawa, Kayoko
    Marchaim, Dror
    Martin, Emily T.
    Tiwari, Namita
    Yousuf, Adnan
    Sunkara, Bharath
    Pulluru, Harish
    Kotra, Harikrishna
    Hasan, Asma
    Bheemreddy, Suchitha
    Sheth, Puja
    Lee, Dae-Won
    Kamatam, Srinivasa
    Bathina, Pradeep
    Nanjireddy, Priyanka
    Chalana, Indu K.
    Patel, Satyam
    Kumar, Sarwan
    Vahia, Amit
    Ku, Kimberly
    Yee, Victoria
    Swan, Jessie
    Pogue, Jason M.
    Lephart, Paul R.
    Rybak, Michael J.
    Kaye, Keith S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (05) : 2452 - 2458
  • [2] Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium Bacteremia in cancer patients
    Ghanem, G.
    Hachem, R.
    Jiang, Y.
    Chemaly, R. F.
    Raad, I.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (09): : 1054 - 1059
  • [3] Persistent vancomycin-resistant Enterococcus faecium bacteremia
    Lukashok, SA
    Casadevall, A
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1997, 6 (04) : 250 - 255
  • [4] VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis
    Depardieu, F
    Kolbert, M
    Pruul, H
    Bell, J
    Courvalin, P
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) : 3892 - 3904
  • [5] Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia
    Ricaurte, JC
    Boucher, HW
    Turett, GS
    Moellering, RC
    LaBombardi, VJ
    Kislak, JW
    CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (01) : 17 - 21
  • [6] Multicenter Clinical Evaluation of VRESelect Agar for Identification of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium
    Anderson, Neil W.
    Buchan, Blake W.
    Young, Carol L.
    Newton, Duane W.
    Brenke, Connie
    Lapsley, Linda
    Granato, Paul A.
    Ledeboer, Nathan A.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (08) : 2758 - 2760
  • [7] Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia
    Ye, Jung-, Jr.
    Shie, Shian-Sen
    Cheng, Chun-Wen
    Yang, Jeng-How
    Huang, Po-Yen
    Wu, Ting-Shu
    Lee, Ming-Hsun
    Huang, Ching-Tai
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2018, 51 (06) : 705 - 716
  • [8] Novel chromogenic medium for detection of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis
    Cuzon, Gaelle
    Naas, Thierry
    Fortineau, Nicolas
    Nordmann, Patrice
    JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (07) : 2442 - 2444
  • [9] Epidemiology of Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis Colonization in Nursing Facilities
    Davis, Elyse
    Hicks, Liam
    Ali, Ihsan
    Salzman, Elizabeth
    Wang, Joyce
    Snitkin, Evan
    Gibson, Kristen
    Cassone, Marco
    Mody, Lona
    Foxman, Betsy
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (01):
  • [10] A novel chromogenic medium for vancomycin-resistant Enterococcus faecium and Enterococcus faecalis detection
    Cuzon, G.
    Naas, T.
    Fortineau, N.
    Nordmann, P.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S22 - S22